Aptevo Therapeutics Inc. Other Current Liabilities
Aptevo Therapeutics Inc. (APVO) had Other Current Liabilities of $1.49 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2025-11-06
- 2025-09-30: Other Liabilities, Current $1.49M.
- 2025-06-30: Other Liabilities, Current $948.00K.
- 2025-03-31: Other Liabilities, Current $1.13M.
- 2024-12-31: Other Liabilities, Current $1.30M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2025-09-30 | $1.49M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $948.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $1.13M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.30M 10-Q · filed 2025-11-06 | |
| 2024-09-30 | $1.43M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $791.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $968.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.14M 10-K · filed 2025-02-14 | |
| 2023-09-30 | $1.31M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $746.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.04M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.10M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $1.17M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $30.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.59M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.09M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $2.59M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $988.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $981.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $1.20M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $1.42M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $921.00K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $907.00K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $944.00K 10-K · filed 2021-03-31 | $1.08M 10-K · filed 2020-03-25 |
| 2019-09-30 | $1.12M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.26M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.35M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $796.00K 10-K · filed 2020-03-25 | |
| 2018-09-30 | $823.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $762.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.70M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.58M 10-K · filed 2019-03-18 | $3.20M 10-K · filed 2018-03-13 |
| 2017-09-30 | $2.29M 10-Q · filed 2017-11-13 | |
| 2016-12-31 | $278.00K 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |